Bain Capital Public Equity LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Bain Capital Public Equity LP
CRD #145650
SEC #801-69070
CIK #0001962552, 0001156175
AUM $242.2 M (2026-03-31)
Employees 26 (15% Investors, 0% Brokers)
Phone617-516-2318
Address200 Clarendon Street
Boston, MA 02116
Source [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn]
Total AUM ($B)
151296302007201320202027
Sector Form 13F Holdings Value ($B)
Alcoa Inc 0.0
Taiwan Semiconductor Manufacturing Co Ltd 0.0
Amazon Com Inc 0.0
Apple Inc 0.0
Performance Food Group Co 0.0
Hubbell Inc 0.0
Banco Santander Sa 0.0
Netflix Inc 0.0
Live Nation Entertainment Inc 0.0
Burlington Stores Inc 0.0
View All
Holdings by Sector ($B)
5.04.03.02.01.00.02011201620212027
Type Form D Funds Date Sold ($M) AUM ($M)
HF Bain Capital Public Equity Enduring Equity Fund LP [2023-02-17] 455.0 575.0
Filed 2025-11-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
Other Bain Capital Public Equity Coinvest IV LP 2022-02-16 21.4
Other Bain Capital Public Equity Coinvest III LP 2020-07-07 27.6
Other Bain Capital Public Equity Coinvest II LP 2020-07-07 1.1
HF Bain Capital Public Equity Global Long Equity Fund LP 2020-02-21 1,184.6
Other Bain Capital Public Equity Coinvest Docusign LP 2018-03-30 27.6
HF Bain Capital Public Equity Global Partners Fund LP [2017-09-29] 514.7 155.9
Filed 2025-10-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Bain Capital Public Equity Global Industrials Fund LP [2017-07-12] 209.7 255.1
Filed 2019-05-31 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Brookside Capital Partners Fund III LP 2015-02-26 134.2
HF Brookside Capital Partners Fund II LP [2012-03-30] 975.5 112.6
Filed 2017-02-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 1 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 3 0.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 4 0.2
By Discretionary
Discretionary 4 0.2
Non-Discretionary 0 0.0
Total 4 0.2
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.2
Total 4 0.2
Form D Directors Role # Filings # Firms 2011 - 2026
Michael Treisman Director, Executive Officer 57 6
Kathleen Rockey Executive Officer 69 5
Andrew Viens Director, Executive Officer 60 5
Sean Doherty Executive Officer 41 5
Michael Goss Executive Officer 26 5
Sally Dornaus Executive Officer 69 4
Mark Moore Executive Officer 32 4
Ranesh Ramanathan Director, Executive Officer 33 3
Adam Koppel Executive Officer 23 3
Colin Campbell Executive Officer 17 3
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001156175]
3 [0001156175]
4 [0001156175]
5 [0001156175]
SC 13G [0001156175]
13F-HR [0001962552]
Form 13D/13G Filer Form 13D/13G Subject Filed
Bain Capital Public Equity Management LLC Immune Design Corp [2017-10-06]
Bain Capital Public Equity Management LLC Mulesoft Inc [2017-03-30]
Brookside Capital Management LLC Concert Pharmaceuticals Inc [2014-02-28]
Brookside Capital Management LLC Dicerna Pharmaceuticals Inc [2014-02-10]
Brookside Capital Management LLC RingCentral Inc [2014-02-07]
Brookside Capital Management LLC RingCentral Inc [2014-02-07]
Form 3/4/5 Subject 2011 - 2026
Brookside Capital Partners Fund LP
Mulesoft Inc
Brookside Capital Management LLC
Brookside Capital Trading Fund LP
Radius Health Inc
Brookside Capital Investors L P
Dicerna Pharmaceuticals Inc
Brookside Capital Investors II LP
Concert Pharmaceuticals Inc
Idenix Pharmaceuticals Inc
Nanosphere Inc
Related Firms State AUM ($B)
Bain Capital Private Equity LP
MA 96.4
Bain Capital Credit LP
MA 76.3
Bain Capital Real Estate LP
MA 10.0
Bain Capital Ventures LP
MA 9.8
BCSF Advisors LP
MA 3.6
Bain Capital Partnership Strategies LP
MA 1.7
Bain Capital Public Equity LP
MA 0.2
Bain Capital Credit CLO Advisors LP
MA 0.0
Comparable Firms State AUM ($B)
Metronome Capital LLP
0.2
Kultura Capital Management LP
UT 0.2
Bandera Partners LLC
NY 0.2
ShoreVest Partners Ltd
0.2
Little Harbor Advisors LLC
MA 0.2
DFN Management LLC
FL 0.2
Tenere Capital LLC
NY 0.2
English Capital Management LLC
MI 0.2
Armatus Capital Management LLC
0.2
Clearfield Capital Management LP
NY 0.2
Terms | Privacy | Providers | Guide
tony@aum13f.com